Track topics on Twitter Track topics that are important to you
The global fractional flow reserve devices market is expected to register a CAGR of close to 14% during the period 2018-2022, according to the latest market research report by Technavio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180614005915/en/
Technavio has published a new market research report on the global fractional flow reserve devices market from 2018-2022. (Graphic: Business Wire)
A key factor driving the market’s growth is the increasing prevalence of CADs. The prevalence of CVDs such as stable angina, unstable angina, MI, and sudden cardiac deaths is increasing globally. By 2022, CVDs are expected to cause approximately 19 million deaths worldwide. In 2013, there were nearly 1.9 million deaths resulting from CVDs in the EU-28. In countries such as the US, nearly 630,000 people die of heart diseases every year.
This market research report on the global fractional flow reserve devices market 2018-2022 provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio predicts an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
In this report, Technavio highlights the increasing number of product approvals as one of the key emerging trends in the global fractional flow reserve (FFR) devices market:
Global fractional flow reserve devices market: Increasing number of product approvals
Until 2014, the global fractional flow reserve devices market consisted of only two major companies. In the past few years, many players have received regulatory approval for their FFR products. Companies such as ACIST Medical Systems launched the ACIST RXi Mini System. The ACIST RXi Mini System allows clinicians to use their choice of 0.014-inch guidewire throughout the FFR procedure while making it easier to access challenging anatomies, maintain wire position and pressure-measurement drift, and obtain post-intervention FFR measurements.
“Many players in the market are increasingly focusing on their R&D efforts on developing FFR products. Such product launches and increased R&D efforts are increasing the adoption of FFR procedures, which, in turn, is driving the market growth,” says a senior analyst at Technavio for research on orthopedics and medical devices.
Global fractional flow reserve devices market: Segmentation analysis
This market research report segments the global fractional flow reserve devices market into the following products (FFR guidewires and FFR monitoring systems), applications (multi-vessel CAD and single-vessel CAD), and key regions (the Americas, APAC, and EMEA).
The FFR guidewires segment held the largest market share in 2017, accounting for nearly 66% of the market. This product segment is expected to dominate the global market throughout the forecast period.
The Americas held the highest share of the global fractional flow reserve devices market in 2017, accounting for a market share of approximately 52%. The market share occupied by this region is anticipated to increase by nearly 2% during 2018-2022.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Five Forces Analysis
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at email@example.com.
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...
Acute Coronary Syndromes ACS
Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflat...
Cardiology is a specialty of internal medicine. Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...